BTI
THC icon

Blue Trust Inc’s Tenet Healthcare THC Stock Holding History

Blue Trust Inc’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7K Buy
207
+34
+20% +$6.25K ﹤0.01% 1454
2026
Q1 		$32.6K Sell
173
-3
-2% -$632 ﹤0.01% 1490
2025
Q4 		$35K Buy
176
+5
+3% +$1.01K ﹤0.01% 1478
2025
Q3 		$34.7K Sell
171
-100
-37% -$17.7K ﹤0.01% 1527
2025
Q2 		$47.7K Buy
271
+100
+58% +$15.1K ﹤0.01% 1469
2025
Q1 		$23K Hold
171
– – ﹤0.01% 1607
2024
Q4 		$21.6K Sell
171
-82
-32% -$12.2K ﹤0.01% 1580
2024
Q3 		$33.7K Buy
253
+4
+2% +$605 ﹤0.01% 1734
2024
Q2 		$26.2K Buy
249
+120
+93% +$14.4K ﹤0.01% 1541
2024
Q1 		$13.6K Sell
129
-48
-27% -$4.31K ﹤0.01% 1363
2023
Q4 		$11K Buy
177
+48
+37% +$3.04K ﹤0.01% 1559
2023
Q3 		$10K Buy
129
+30
+30% +$2.24K ﹤0.01% 1420
2023
Q2 		$6K Sell
99
-82
-45% -$5.84K ﹤0.01% 1491
2023
Q1 		$9K Sell
181
-284
-61% -$15.8K ﹤0.01% 1637
2022
Q4 		$24K Buy
465
+117
+34% +$5.41K ﹤0.01% 1242
2022
Q3 		$18K Buy
348
+261
+300% +$15.5K ﹤0.01% 1137
2022
Q2 		$7K Buy
+87
New +$6.05K ﹤0.01% 1346

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Blue Trust Inc's THC Position: Q2 2026 in Review

Blue Trust Inc increased its Tenet Healthcare (THC) stake by 20% in Q2 2026, buying an estimated $6.25K and bringing the position to 207 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Blue Trust Inc first reported a position in THC in Q2 2022 and has held it in 17 quarters since. The position peaked at $47.7K in Q2 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Blue Trust Inc held 207 shares of Tenet Healthcare worth $38.7K as of Q2 2026.
  • Blue Trust Inc bought 34 Tenet Healthcare shares in Q2 2026, an estimated $6.25K.
  • Tenet Healthcare made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1454 holding.
  • Blue Trust Inc first reported a position in Tenet Healthcare in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Tenet Healthcare position peaked at $47.7K in Q2 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.